ACP Diabetes Monthly

GLP-1 receptor agonists show effects on substance disorders, infections

Researchers should examine the effects of glucagon-like peptide 1 (GLP-1) receptor agonists on multiple diseases, according to the authors of a systematic review that looked at 175 health outcomes in patients taking diabetes medications.

Micronutrient deficiencies, especially vitamin D, common in type 2 diabetes

Approximately 45% of patients with type 2 diabetes were deficient in multiple micronutrients, with vitamin D deficiency the most common at approximately 61%, a meta-analysis of 132 studies found.

SGLT-2 inhibitors, GLP-1 receptor agonists lower COPD exacerbation risk

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists were associated with significant reductions in severe chronic obstructive pulmonary disease (COPD) exacerbations compared with dipeptidyl peptidase-4 inhibitors, an observational study found.

Test yourself

MKSAP quiz: Prediabetes treatment

This month's quiz asks readers to evaluate a 27-year-old with prediabetes who is worried about her risk for progressing to type 2 diabetes.

Keeping tabs

Spotlight on inpatient diabetes care

Recent studies looked at the use of continuous glucose monitoring and metformin in the hospital.

From I.M. Matters Weekly

SGLT-2, GLP-1 effects on cardiovascular risk differ by age

Older patients had a greater relative reduction in major adverse cardiovascular events with sodium-glucose cotransporter-2 (SGLT-2) inhibitors versus glucagon-like peptide-1 (GLP-1) receptor agonists, a meta-analysis of more than 600 studies found.

Health care costs lower for patients with diabetes in years after bariatric surgery vs. before

Overall health care expenditures decreased to similar extents after Roux-en-Y gastric bypass and sleeve gastrectomy, primarily because of reductions in medication expenses, according to a retrospective cohort study.

FDA Update

FDA warns about smartphone systems, glucose tests

Smartphone settings may cause notifications from diabetes devices to be missed, and some glucose and ketone meters were recalled.